Medical Cannabis in Oncology: a Valuable Unappreciated Remedy or an Undesirable Risk?
The use of the cannabis plant by cancer patients has been rising significantly in the past few years worldwide, primarily driven by public demand.
The use of the cannabis plant by cancer patients has been rising significantly in the past few years worldwide, primarily driven by public demand.
Recently, many countries have enacted new cannabis policies, including decriminalization of cannabis possession as well as legalization of medical and recreational cannabis.
Many cultures throughout history have used cannabis to treat a variety of painful ailments. Neuropathic pain is a complicated condition that is challenging to treat with our current medications.
The use of cannabis for medical purposes has been recently legalised in many countries including the Czech Republic.
The use of cannabis for medical purposes has been recently legalised in many countries including the Czech Republic.
Lung cancer continues to be one of the most common causes of cancer death despite understanding the major cause of the disease: cigarette smoking. Smoking increases lung cancer risk 5- to 10-fold with a clear dose-response relationship
The use of medical marijuana in cancer care presents a dilemma for both patients and physicians.
Medical cannabis, or cannabinoid-based products, continues to grow in popularity globally, driving the evolution of regulatory access frameworks; cancer patients and caregivers often rely on guidance from their physicians regarding cannabinoid-based treatments.
Medical cannabis, or cannabinoid-based products, continues to grow in popularity globally, driving the evolution of regulatory access frameworks; cancer patients and caregivers often rely on guidance from their physicians regarding cannabinoid-based treatments.
Insufficient management of cancer-associated chronic and neuropathic pain adversely affects patient quality of life.